These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29778562)

  • 21. Comment on: High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Thamlikitkul V; Tiengrim S; Tribuddharat C
    J Antimicrob Chemother; 2007 Jul; 60(1):177-8; author reply 178-9. PubMed ID: 17496287
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of an automated system for the detection of carbapenem resistant Acinetobacter baumannii and assessment of metallo-β-lactamase production using two different phenotyping methods.
    Aybey AD; Aksit F; Oz Y; Kiremitci A; Durmaz G
    J Microbiol Methods; 2011 Jul; 86(1):121-3. PubMed ID: 21530594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii.
    Jo J; Ko KS
    Microbiol Spectr; 2021 Oct; 9(2):e0101021. PubMed ID: 34523993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
    Morfin-Otero R; Dowzicky MJ
    Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the variability in the susceptibility of Acinetobacter baumannii to tigecycline in the same medium with two methods of quantitative diffusion different commercial].
    Tejero R; Causse M; Moreno M; Solís F; Rodríguez-López F; Casal M
    Rev Esp Quimioter; 2012 Sep; 25(3):189-93. PubMed ID: 22987264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INVESTIGATION OF TIGECYCLINE SUSCEPTIBILITY OF MULTIDRUG-RESISTANT
    Çalışkan E; İnce N; Akar N; Öztürk CE
    Acta Clin Croat; 2022 Mar; 61(1):46-51. PubMed ID: 36398087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of tigecycline and colistin against A. baumannii clinical bloodstream isolates during an 8-year period.
    Spiliopoulou A; Jelastopulu E; Vamvakopoulou S; Bartzavali C; Kolonitsiou F; Anastassiou ED; Christofidou M
    J Chemother; 2015 Oct; 27(5):266-70. PubMed ID: 24827985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
    Tiengrim S; Tribuddharat C; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance.
    Sinirtaş M; Akalin H; Gedikoğlu S
    Int J Infect Dis; 2009 Sep; 13(5):e217-20. PubMed ID: 19230734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.
    Seifert H; Stefanik D; Wisplinghoff H
    J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative evaluation of minocycline susceptibility testing methods in carbapenem-resistant Acinetobacter baumannii.
    Dimitriadis P; Protonotariou E; Varlamis S; Poulou A; Vasilaki O; Metallidis S; Tsakris A; Malisiovas N; Skoura L; Pournaras S
    Int J Antimicrob Agents; 2016 Sep; 48(3):321-3. PubMed ID: 27451087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Vourli S; Dafopoulou K; Vrioni G; Tsakris A; Pournaras S
    J Antimicrob Chemother; 2017 Sep; 72(9):2528-2530. PubMed ID: 28605445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
    Liu B; Bai Y; Liu Y; Di X; Zhang X; Wang R; Wang J
    J Chemother; 2015 Oct; 27(5):271-6. PubMed ID: 25068186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Resistance of
    Qu JY; Ü XJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):248-252. PubMed ID: 28612536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
    Cai X; Yang Z; Dai J; Chen K; Zhang L; Ni W; Wei C; Cui J
    Int J Antimicrob Agents; 2017 May; 49(5):609-616. PubMed ID: 28315729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.
    Capone A; D'Arezzo S; Visca P; Petrosillo N;
    J Antimicrob Chemother; 2008 Aug; 62(2):422-3. PubMed ID: 18424790
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of insertion sequence Aba-1 and AdeS in reduced tigecycline susceptibility in MDR-Acinetobacter baumannii clinical isolates from Cairo, Egypt.
    Hassan R; Mukhtar A; Hasanin A; Ghaith D
    J Chemother; 2018 Apr; 30(2):89-94. PubMed ID: 29108486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Evaluation of Broth Microdilution with Polystyrene and Glass-Coated Plates, Agar Dilution, E-Test, Vitek, and Disk Diffusion for Susceptibility Testing of Colistin and Polymyxin B on Carbapenem-Resistant Clinical Isolates of Acinetobacter baumannii.
    Singhal L; Sharma M; Verma S; Kaur R; Britto XB; Kumar SM; Ray P; Gautam V
    Microb Drug Resist; 2018 Oct; 24(8):1082-1088. PubMed ID: 29406804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.